Lani Cupo
Overview
Explore the profile of Lani Cupo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prenatal cannabis exposure in the clinic and laboratory: What do we know and where do we need to go?
Cupo L, Dominguez-Cancino K, Nazif-Munoz J, Chakravarty M
Drug Alcohol Depend Rep
. 2024 Oct;
13:100282.
PMID: 39430603
Coincident with the legalisation of cannabis in many nations, rates of cannabis use during pregnancy have increased. Like prior investigations on smoking and alcohol, understanding how prenatal cannabis exposure (PCE)...
2.
Bussy A, Levy J, Best T, Patel R, Cupo L, Van Langenhove T, et al.
Hum Brain Mapp
. 2023 Mar;
44(7):2684-2700.
PMID: 36895129
Recent studies have reported early cerebellar and subcortical impact in the disease progression of genetic frontotemporal dementia (FTD) due to microtubule-associated protein tau (MAPT), progranulin (GRN) and chromosome 9 open...
3.
Valiquette V, Guma E, Cupo L, Gallino D, Anastassiadis C, Snook E, et al.
Neuroimage
. 2023 Jan;
269:119888.
PMID: 36681136
Our current understanding of litter variability in neurodevelopmental studies using mice may limit translation of neuroscientific findings. Higher variance of measures across litters than within, often termed intra-litter likeness, may...
4.
Guma E, Cupo L, Ma W, Gallino D, Moquin L, Gratton A, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2022 Sep;
120:110642.
PMID: 36150422
Prenatal exposure to maternal immune activation (MIA) and chronic adolescent cannabis use are both risk factors for neuropsychiatric disorders. However, exposure to a single risk factor may not result in...
5.
Paquin V, Cupo L, Malla A, Iyer S, Joober R, Shah J
Psychol Med
. 2021 Sep;
53(5):2008-2016.
PMID: 34538292
Background: Rapid progression from the first identifiable symptom to the onset of first-episode psychosis (FEP) allows less time for early intervention. The aim of this study was to examine the...
6.
Plitman E, Bussy A, Valiquette V, Salaciak A, Patel R, Cupo L, et al.
Neuroimage
. 2021 Jun;
238:118172.
PMID: 34082116
Many magnetic resonance imaging (MRI) measures are being studied longitudinally to explore topics such as biomarker detection and clinical staging. A pertinent concern to longitudinal work is MRI scanner upgrades....
7.
Cupo L, Plitman E, Guma E, Chakravarty M
Transl Psychiatry
. 2021 Apr;
11(1):217.
PMID: 33850098
Acute exposure to cannabis has been associated with an array of cognitive alterations, increased risk for neuropsychiatric illness, and other neuropsychiatric sequelae including the emergence of acute psychotic symptoms. However,...
8.
Cupo L, McIlwaine S, Daneault J, Malla A, Iyer S, Joober R, et al.
Schizophr Bull
. 2021 Jan;
47(3):604-614.
PMID: 33410487
Prospective population studies suggest that psychotic syndromes may be an emergent phenomenon-a function of severity and complexity of more common mental health presentations and their nonpsychotic symptoms. Examining the relationship...
9.
Sherman A, Cupo L, Mithlo N
PLoS One
. 2020 Feb;
15(2):e0228784.
PMID: 32092065
Given the problematic depictions of Native Americans and the pervasive cultural biases that exist, we sought to understand how contemporary educational practices in museums might encourage viewers to consider the...